Indaptus Therapeutics (INDP) vs Larimar Therapeutics (LRMR)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Oct 7, 2026.
Summary
Indaptus Therapeutics (INDP) has outperformed Larimar Therapeutics (LRMR) over the past year, losing 38.8% versus a loss of 41.7%. Indaptus Therapeutics is the larger company by market cap ($301.1 million vs $285.7 million), about 1.1 times the size.
Summary generated from market data by MetaCap's automated system. Methodology
Relative performance
Percent change in share price from the first common trading day shown; excludes dividends.
Head-to-head
| Metric | INDP | LRMR |
|---|---|---|
| Share price | $2.26 | $2.75 |
| Market cap | $301.13M | $285.68M |
| 1-day change | -12.74% | -1.08% |
| YTD return | -22.34% | -27.82% |
| 1-year return | -38.75% | -41.74% |
| 5-year return | — | -77.31% |
| EPS (TTM) | $-6.15 | $-1.99 |
| Dividend yield | 0.00% | 0.00% |
| Annual dividend | $0.00 | $0.00 |
| 52-week high | $5.96 | $6.42 |
| 52-week low | $0.92 | $2.72 |
| Distance from 52-week high | -62.08% | -57.17% |
| Average volume | 822.38K | 1.33M |
| Shares outstanding | 133.24M | 103.88M |
| Sector | Health Care | Health Care |
| Industry | Biotechnology: Pharmaceutical Preparations | Biotechnology: Pharmaceutical Preparations |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
INDP vs LRMR FAQ
Which is bigger, Indaptus Therapeutics or Larimar Therapeutics?
Indaptus Therapeutics (INDP) is larger, with a market capitalization of $301.13M compared with $285.68M for Larimar Therapeutics (LRMR).
Which stock has performed better over the past year, INDP or LRMR?
INDP returned -38.75% over the past 12 months, compared with -41.74% for LRMR (price return, excluding dividends). Past performance does not predict future results.
Are Indaptus Therapeutics and Larimar Therapeutics in the same industry?
Yes. Both are classified in the Biotechnology: Pharmaceutical Preparations industry within the Health Care sector.